KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Gains from Investment Securities (2016 - 2025)

Fulgent Genetics' Gains from Investment Securities history spans 10 years, with the latest figure at $18000.0 for Q2 2025.

  • For Q2 2025, Gains from Investment Securities fell 30.77% year-over-year to $18000.0; the TTM value through Jun 2025 reached $18000.0, down 30.77%, while the annual FY2024 figure was $7000.0, 99.74% down from the prior year.
  • Gains from Investment Securities for Q2 2025 was $18000.0 at Fulgent Genetics, down from $111000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $2.2 million in Q3 2023 and bottomed at -$1.2 million in Q3 2024.
  • The 5-year median for Gains from Investment Securities is $21000.0 (2024), against an average of $29941.2.
  • The largest annual shift saw Gains from Investment Securities skyrocketed 12166.67% in 2021 before it plummeted 152.78% in 2024.
  • A 5-year view of Gains from Investment Securities shows it stood at $216000.0 in 2021, then dropped by 1.85% to $212000.0 in 2022, then skyrocketed by 936.79% to $2.2 million in 2023, then tumbled by 99.04% to $21000.0 in 2024, then dropped by 14.29% to $18000.0 in 2025.
  • Per Business Quant, the three most recent readings for FLGT's Gains from Investment Securities are $18000.0 (Q2 2025), $111000.0 (Q1 2025), and $21000.0 (Q4 2024).